The role of hyaluronic acid (hyaluronan) in health and disease: interactions with cells, cartilage and components of synovial fluid.
Intra-articular administration of hyaluronic acid (Hyaluronan) (HA) is now gaining widespread acceptance for the treatment of osteoarthritis (OA), even though little is known of its mechanism of action. In vitro and in vivo studies have shown that HA is able to modulate a variety of cellular functions, suppress the activities of pro-inflammatory mediators and can attenuate the nociceptive response in arthritic joints. However, recent studies with animal models of non-inflammatory OA have questioned the ability of HA to protect articular cartilage degeneration directly. The objective of this review is to examine some aspects of HA chemistry and pharmacology in relation to its interactions with cells, cartilage and the components of synovial fluid.
Ghosh
P
P
Raymond Purves Bone & Joint Research Laboratories, University of Sydney, Royal North Shore Hospital of Sydney, St. Leonards, NSW, Australia.
D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology; D002358:Cartilage, Articular / Q000166:cytology / Q000378:metabolism*; D006801:Humans; D006820:Hyaluronic Acid / Q000494:pharmacology / Q000502:physiology* / Q000627:therapeutic use; D010003:Osteoarthritis / Q000188:drug therapy / Q000378:metabolism*; D011817:Rabbits; D012756:Sheep; D013582:Synovial Fluid / Q000166:cytology / Q000378:metabolism*
D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D006820:Hyaluronic Acid